British drug giant, GlaxoSmithKline admitted that some of its executives in China appear to have violated Chinese law in a bribery and corruption scandal which has hit the firm.
GSK is being investigated by Chinese police for alleged corruption, price fixing.
"Certain senior executives of GSK China who know our systems well, appear to have acted outside of our processes and controls which breaches Chinese law," Abbas Hussain, GSK's international president said in a statement.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
GSK needs to pull out of China immediately.China cannot be reasoned with and a case in their court is unwinnable.
ReplyDelete